Renal Glucose Handling: Impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes

OBJECTIVE: Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, stimulates glycosuria and lowers glycemia in patients with type 2 diabetes (T2DM). The objective of this study was to assess the pharmacodynamics of ipragliflozin in T2DM patients with impaired renal function. RESEARCH DESIGN AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrannini, Ele, Veltkamp, Stephan A., Smulders, Ronald A., Kadokura, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631866/
https://www.ncbi.nlm.nih.gov/pubmed/23359360
http://dx.doi.org/10.2337/dc12-1503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631866/
https://www.ncbi.nlm.nih.gov/pubmed/23359360
http://dx.doi.org/10.2337/dc12-1503

Ejemplares similares